| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.096 | 0.2 |